Log in to save to my catalogue

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN...

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000512502

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study

About this item

Full title

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Neuroendocrinology, 2021-09, Vol.111 (10), p.951-964

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Introduction: Gastroenteropancreatic neuroendocrine carcinomas (GEPNEC) are characterized by a heterogeneous molecular profile and a poor prognosis. Circulating tumour DNA (ctDNA) analysis may be useful for NEC management. This study aimed at describing ctDNA mutations, to assess their predictive value for response to chemotherapies, and their chan...

Alternative Titles

Full title

ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1159_000512502

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000512502

Other Identifiers

ISSN

0028-3835

E-ISSN

1423-0194

DOI

10.1159/000512502

How to access this item